Introduction
The kidney has the ability to completely recover from an ischemic or toxic insult. In patients and animals, survival renal proximal tubule cells (RPTC) that do not die or detach from the basement membrane are thought to contribute to the regeneration of the tubular epithelium and the restoration of overall renal function. RPTC migration, proliferation, and repair of physiological functions are three crucial processes needed for structural and functional regeneration of the nephron (26).
The molecular mechanisms that regulate renal tissue repair are not fully understood.
Previous studies have indicated that activation of growth factor receptors with exogenous growth factors promotes RPTC proliferation and migration (24) . Other studies have shown that the epidermal growth factor (EGF) receptor (EGFR) is upregulated following ischemia/reperfusion injury in rats and rabbits, and in humans with ARF (4, 18, 36, 43 ).
In addition, RPTC EGFR phosphorylation status is increased in the early phase of renal injury (47). Heparin-binding EGF (HB-EGF), one EGFR ligand, has been identified in RPTC and HB-EGF expression increased following renal injury (11). EGF is localized to the ascending limb of Henle and the distal convoluted tubule, but not the proximal tubule in the healthy kidneys. However, in post-ischemic kidneys, EGF immunoreactivity was associated with proximal tubules, suggesting that EGF may migrate to the RPTC and contribute to repair following renal injury (43). Very recently, Wang et al., examined the role of the EGFR in renal repair using mice with an EGFR point mutation that reduces receptor tyrosine kinase activity and found that profound decrease in the rate of both of functional and structural recovery following acute renal failure induced by mercuric An in vitro model is needed that mimics the recent in vivo study in mice to study the activation and signaling of the EGF receptor that leads to RPTC proliferation and migration following renal injury. We observed previously that isolated renal proximal Final Accepted Version (F-00035-2004.R1) tubules proliferate and migrate in culture to form a confluent monolayer in the absence of exogenous growth factors (28, 31). Further, confluent RPTC subjected to mechanical and oxidant injury migrated, proliferated, and reached monolayer confluence in the absence of exogenous growth factors (7) (27). Mechanical injury is a commonly used model to study repair and regeneration in RPTC and many other cell types (1, 13, 41).
The advantage of this model is the clear delineation of cell loss and the ability to examine cell migration and proliferation in defined areas. Consequently, we used the above models to determine the role of the EGFR and associated signaling pathways in RPTC migration and proliferation following plating and mechanical injury. supplemented with 15 mM HEPES buffer, 2.5 mM L-glutamine, 1 µM pyridoxine HCL, 15 mM sodium bicarbonate, and 6 mM lactate. Hydrocortisone (50 nM), selenium (5 ng/ml), human transferrin (5 µg/ml), bovine insulin (10 nM) and L-ascorbic acid-2-phosphate (50 µM) were added daily to fresh culture medium.
Materials and Methods

Chemicals and reagents.
Experimental Protocols. To determine RPTC proliferation and spreading following plating, isolated tubules were plated at 1mg protein/well. On day 3, RPTC were incubated in the presence or absence of various pharmacological inhibitors for different time periods as indicated in figure legends. To measure the rate of RPTC proliferation following mechanical injury, RPTC were grown to confluence (day 6) and monolayers were wounded by scraping cells off the plate with a hair comb to produce four 2 mm wide swipes. Similar wounding was produced again perpendicular to the original swipe.
Control cultures were mock-wounded by moving the comb as described above through the medium, but without damaging the cell monolayer. After washing once with PBS to remove cell debris, cells were incubated for 24 hr in the presence or absence of various pharmacological inhibitors. To measure RPTC migration, RPTC were grown to confluence, and monolayers wounded with a rubber policeman to produce a linear 4 mm swipe. After washing once with PBS, cells were incubated for 24 hr in medium in the presence of 0.5 µg/ml mitomycin C to block any proliferation. Cell migration was determined using a microscope and camera, and wound area calculated using NIH image software (1.6).
MTT assay. The 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) assay was used to assess cell proliferation (16, 20 for cell proliferation following plating using the specific EGF receptor inhibitor AG1478
(32). Three days after plating increasing concentrations of AG1478 were added and cell proliferation determined 48 hr later using the MTT assay. AG1478 decreased RPTC proliferation in a concentration-dependent manner with maximal inhibition at 10 µM were observed using HB-EGF ( Figure 1D ).
To determine whether the EGFR also mediates RPTC proliferation following injury, we examined the effect of AG1478 on RPTC proliferation following mechanical injury.
Confluent RPTC were subjected to mechanical injury and then incubated in the presence and absence of AG1478 for 24 hr. Confluent RPTC were growth arrested, with approximately 2% of the cells in S-phase ( Figure 1E ). The number of RPTC in S-phase increased to approximately 7% after mechanical injury and AG1478 blocked the increase in the number of cells in S-phase. Together, these data illustrate that the EGFR is critical in regulating RPTC proliferation after plating and mechanical injury in the absence of exogenous growth factors. In addition, exogenous EGF and HB-EGF are able to further stimulate the proliferation of RPTC.
EGFR activation after RPTC plating, injury and EGF exposure. RPTC were cultured
for four days and then incubated in the absence and presence of 10 ng/ml EGF for 0-60 min. EGFR phosphorylation was measured using immunoblot analysis with an antibody that recognizes the phosphorylation of the EGF receptor at tyrosine 1068 (22). Total EGFR content was measured using immunoblot analysis and an antibody that recognizes the EGFR independent of its phosphorylation state. EGFR phosphorylation (p-EGFR) was observed in RPTC undergoing proliferation, was increased in the presence of exogenous EGF within 5 min and was maintained at the elevated level for 30 min ( Figure   2A ). Treatment with AG1478 completely blocked EGF receptor phosphorylation ( Figure   2B ). Total EGF receptor levels did not change under these experimental conditions.
Low levels of EGFR phosphorylation were observed in non-wounded confluent monolayers ( Figure 2C ). EGFR phosphorylation increased within 10 min of mechanical injury, remained elevated through 60 min, and was blocked by AG1478. Total EGFR levels did not change under these experimental conditions. These data illustrate that the EGFR is activated (i.e. phosphorylated) during proliferation following plating in the absence of exogenous growth factors, in confluent RPTC and following mechanical injury. Further, exogenous EGF further activated the EGFR and AG1478 completely blocked EGFR phosphorylation. To confirm that LY294002 and U0126 selectively inhibited their respective kinases, Akt and ERK1/2 activation were monitored using immunoblot analysis and antibodies that recognize phosphorylated and total Akt and ERK1/2 as described above. LY294002
EGFR mediates activation of Akt and ERK1
blocked Akt phosphorylation and U0126 blocked ERK1/2 phosphorylation of RPTC following plating in the presence and absence of exogenous EGF at 10 min and 24 hr (Figure 4 C, E, and F). Similarly, these two inhibitors also abolished phosphorylation of Akt and ERK1/2 at 5 min following mechanical injury ( Figure 4D ). LY294002 had no effect on ERK1/2 phosphorylation and U0126 had no effect on Akt phosphorylation under the same conditions. These data strongly suggest that although both PI3/Akt and ERK pathway are activated under these experimental conditions, PI3K is responsible for RPTC proliferation.
EGFR mediates RPTC migration following after plating, injury, and in response to
EGF. To elucidate the role of the EGFR in RPTC migration following injury, confluent RPTC were mechanically injured and then incubated for 24 hr in the absence or presence of AG1478 and/or exogenous EGF. RPTC migrated into the denuded area and partially filled the wound area 24 hr following mechanical injury ( Figure 5 ). Exogenous EGF enhanced wound closure while RPTC migration was blocked by AG1478 in the presence or absence of exogenous EGF. These observations suggest that the EGFR mediates RPTC migration following injury and in response to EGF.
p38, but not PI3K and ERK, pathways mediates RPTC migration. It has been
reported that ERK, PI3K and p38 mediate cell migration in different cell types (35). To determine whether RPTC migration following mechanical injury was mediated by ERK1/2, p38 and/or PI3K pathways, inhibitors of ERK1/2 (U0126), Akt (LY294002), or p38 (SB203580) were added immediately prior to mechanical injury, and cell migration determined 24 hr later. RPTC migration was inhibited by SB203580, but not U0126 or LY294002, suggesting that p38, but neither ERK1/2 nor PI3K mediates RPTC migration ( Figure 6A ). The effectiveness of LY294002 and U0126 in inhibiting Akt and ERK1/2 was shown in Figure 4D .
To determine whether p38 activation was induced following injury, RPTC were subjected to mechanical injury and then immunoblot analysis using an antibody that specifically recognizes phosphorylated p38. p38 is constitutively phosphorylated in confluent RPTC and its phosphorylation increased within 5 min following mechanical injury ( Figure 6B ). Total p38 protein levels did not change over the experimental period.
Treatment of cells with SB203580 blocked p38 phosphorylation under basal and following injury ( Figure 6C ). In the presence of AG1478, mechanical injury-induced p38 phosphorylation also was inhibited ( Figure 6D ). These data suggest that the EGFR mediates p38 activation following injury, but the constitutive activation of this kinase is independent of EGFR.
Discussion
Previous studies have shown that RPTC can migrate, proliferate and repair physiological functions following oxidant, toxicant and mechanical injury in the absence of exogenous growth factors (7, 27, 29). Further, exogenous EGF stimulated migration and proliferation following oxidant and mechanical injury (2, 30, 41). However, the physiological role of EGFR in these RPTC regenerative processes is still not clear. In this study, we demonstrated that the EGFR is constitutively activated following plating in the absence of exogenous growth factors and is further stimulated by mechanical injury.
Further, the specific EGFR inhibitor AG1478 blocked EGFR activation and blocked RPTC proliferation and migration following mechanical injury. AG1478 decreased but did not completely block RPTC proliferation following plating. These results show that EGFR is indispensable for RPTC proliferation and migration and clearly assigns the EGFR to the regulation of RPTC regenerative responses. In spite of the importance of EGFR in mediating RPTC proliferation and migration, it is possible that other growth factor receptors also may play a role since AG1478 did not fully inhibit RPTC proliferation following plating.
These results are in agreement with the recent findings of Wang et al., who observed that mice containing a mutation in the EGFR that results in reduced receptor kinase activity exhibited less renal DNA synthesis than wild-type mice treated with mercuric chloride [6] . Further, while the acute renal failure resolved over six days in wild-type mice, the acute renal failure in the mice containing the mutation in the EGFR did not resolve.
The mechanism by which EGFR is activated following plating and mechanical injury remains to be studied. In the absence of an influx of an EGF receptor ligand from a distal site in vivo, EGFR activation has been thought to be associated with autocrine/paracrine secretion of soluble ligands (33). Since our culture system does not contain serum or EGF ligands, it is possible that EGFR activation following plating and injury may be induced by an autocrine mechanism. In this regard, multiple growth factors including EGF, TGF-α, HB-EGF, amphiregulin, batacelluin serve as EGFR ligands (9). Among them, HB-EGF is expressed in RPTC and exogenous HB-EGF is able to stimulate RPTC proliferation (11) ( Figure 1D ). Further, it has been reported that HB-EGF expression is increased following renal ischemia/reperfusion injury (11). A previous study has confirmed the existence of an autocrine EGFR loop with HB-EGF as one of its ligand in the wounding healing of keratinocytes (21). Thus, it will be interesting to examine whether HB-EGF plays an autocrine role in RPTC proliferation and migration.
Alternatively, EGFR also may be activated via a ligand-independent mechanism, involving cell adhesion to extracellular matrix. Moro et al., showed that EGFR can be activated following cell plating on various extracellular substrates that bind integrins Immunoblot analysis using antibodies to phospho-Akt, phospho-ERK1/2, total Akt or total ERK1/2. µM U0126. In some samples, RPTC were exposed to 10 ng/ml EGF beginning on day 3.
Cell cycle was analyzed using flow cytometry. Data are expressed as X + SEM, N=3.
Bars with different superscripts are significantly different from one another (p < 0.05).
Samples were taken 10 min (C) or 24 hr (E and F) after exposure to EGF or 5 min following injury (D) for immunoblot analysis using antibodies to phospho-Akt, phospho-ERK1/2, total Akt and total ERK1/2. following mechanical injury. RPTC were subjected to immunoblot analysis using antibodies to phospho-p38 and protein loading was monitored using an antibody to total p38 protein. 
